Anthrax Vaccine Market - Recombinant Protective Antigen Technology...

أضاف وظيفة جديدة Health

2026-07-20 07:43:19 -

Anthrax Vaccine Market - Recombinant Protective Antigen Technology Improving Vaccine Safety Profile

Market Overview The anthrax vaccine market is recombinating as recombinant protective antigen technology improves vaccine safety profile. The Anthrax Vaccine Market is projected to grow through 2030, driven by AVA reactogenicity concern, rPA vaccine clinical development, improved tolerability expectation, and modern vaccine platform supporting next-generation anthrax vaccine with enhanced...

0 التعليقات 0 المشاركات 3 مشاهدة 0 معاينة